Astria Therapeutics (ATXS) Earnings Date & Reports

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATXS is expected to report earnings to fall 16.38% to -48 cents per share on August 11

Astria Therapeutics ATXS Stock Earnings Reports

Q2'25

Est.

$-0.49

Q1'25

Missed

by $0.13

Q4'24

Beat

by $0.01

Q3'24

Est.

$-0.42

Q2'24

Missed

by $0.06

The last earnings report on May 13 showed earnings per share of -57 cents, missing the estimate of -44 cents. With 373.27K shares outstanding, the current market capitalization sits at 223.48M.

View a ticker or compare two or three

Compare

ATXS